Verrica Pharmaceuticals Stock Forecast

VRCA's stock price has decreased by -94.13% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Verrica Pharmaceuticals stock ranges from a low of $2.00 to a high of $10. The average analyst price target of $6.00 forecasts a 1,113.10% increase in the stock price over the next year.

Price Target: $6.00 (+1,113.10%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$6.00	$10	$10
Change	+304.37%	+1113.1%	+1921.8%	+1921.8%

* Price targets were last updated on Nov 5, 2024.

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 14, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

17.24M

from 7.57M

127.85%

from 7.57M

Revenue Next Year

35.36M

from 17.24M

105.09%

from 17.24M

EPS This Year

-0.29

from -1.48

EPS Next Year

-0.22

from -0.29

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	12.00M	9.03M	5.12M	7.57M	17.24M	35.36M	57.00M
Revenue Growth	-	-	-24.73%	-43.27%	47.66%	127.85%	105.09%	61.23%
EPS	-1.71	-1.30	-0.72	-1.48	-1.48	-0.29	-0.22	-0.09
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	26.7M	52.5M	126.0M
Avg	17.2M	35.4M	57.0M
Low	7.5M	23.2M	20.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	252.5%	204.5%	256.4%
Avg	127.8%	105.1%	61.2%
Low	-0.6%	34.6%	-43.3%

EPS Forecast

EPS	2025	2026	2027
High	-0.26	-0.18	-0.02
Avg	-0.29	-0.22	-0.09
Low	-0.31	-0.24	-0.16

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.